Home › NDC Lookup › RxCUI directory › RxCUI 251426

Granisetron 0.2 MG/ML Oral Solution — RxCUI 251426

RxNorm drug concept · Semantic clinical drug
RxCUI 251426 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI251426
Official nameGranisetron 0.2 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asgranisetron 1 MG per 5 ML Oral Solution; granisetron 2 MG in 10 mL Oral Solution; granisetron 0.2 MG/ML (granisetron hydrochloride 0.224 MG/ML) Oral Solution
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Granisetron: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Granisetron is an anti-nausea medicine. It's mainly used to prevent nausea and vomiting that cancer chemotherapy or radiation therapy can cause. Depending on which product you've b...
  • The Sancuso patch delivers granisetron slowly through your skin over up to 7 days — you apply it to your upper outer arm at least 24 hours before chemotherapy starts and leave it o...
  • How does the Sancuso patch work differently from the pill or injection?
  • The most common ones are headache and constipation — these are the side effects most often reported in clinical studies. Some people also notice fever, stomach pain, or a slight ch...
📖 Read our full Granisetron guide →

🕸️ Concept Web — How Granisetron 0.2 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Granisetron 0.2 MG/ML Oral Solution RxCUI 251426

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Granisetron 26237
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Granisol 763504
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Granisetron Oral Solution 372349
    • Granisetron Oral Liquid Product 1156891
    • Granisetron Oral Product 1156892
    • Granisetron Oral Solution [Granisol] 763506
    • Granisol Oral Liquid Product 1172655
    • Granisol Oral Product 1172656
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Granisetron 0.2 MG/ML SCDC · 334912
  • Granisetron Oral Solution SCDF · 372349
  • Granisetron Oral Liquid Product SCDG · 1156891
  • Granisetron Oral Product SCDG · 1156892

Brand-Name Concepts

  • Granisetron 0.2 MG/ML Oral Solution [Granisol] SBD · 763507
  • Granisetron 0.2 MG/ML [Granisol] SBDC · 763505
  • Granisetron Oral Solution [Granisol] SBDF · 763506
  • Granisol Oral Liquid Product SBDG · 1172655
  • Granisol Oral Product SBDG · 1172656
  • Granisol BN · 763504

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 251426 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
80056-0801-30 30 mL in 1 BOTTLE, GLASS (80056-801-30) Granisol Intra-Sana Laboratories 2025-07-04
Observed labelers: Intra-Sana Laboratories (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.